Osman Karaarslan

Osman Karaarslan

Auto-generated profile, based on publicly available information

Osman Karaarslan

Department of Cardiology Hitit University Erol Olçok Education and Research Hospital Corum Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2026 in Exploration of Cardiology
Verified
Journal Article
Open access
PDF file
ÖÇÖmer Burak Çelik
Ömer Burak Çelik
MKMacit Kalçık
Macit Kalçık
ASAbdullah Sarıhan
Abdullah Sarıhan
MYMehmet Mustafa Yılmaz
Mehmet Mustafa Yılmaz
OKOsman Karaarslan
Osman Karaarslan
YKYusuf Karavelioğlu
Yusuf Karavelioğlu
High-sensitivity cardiac biomarkers have transformed modern cardiology by enabling earlier diagnosis and refined risk stratification in acute coronary syndromes and heart failure. However, increasing analytical sensitivity has also amplified the clinical impact of immunoassay interferences, particularly those caused by heterophile antibodies. These endogenous antibodies can interact with assay antibodies and generate false-positive or false-negative results, most notably in sandwich immunoassays used for cardiac troponins and natriuretic peptides. Persistent, clinically implausible biomarker elevations related to heterophile antibody interference have led to unnecessary invasive procedures, inappropriate pharmacologic treatment, repeated hospital admissions, and prolonged diagnostic uncertainty. Conversely, false-negative results may delay diagnosis, result in inappropriate discharge, and contribute to adverse clinical outcomes in high-risk patients. This review summarizes the immunological basis and analytical mechanisms of heterophile antibody interference, highlights cardiac biomarkers most commonly affected, and outlines key clinical red flags that should prompt suspicion. Practical laboratory strategies include polyethylene glycol precipitation as an initial approach to detect antibody-mediated interference, followed by dilution studies, heterophile blocking reagents, and cautiously interpreted alternative platform testing within assay-specific reference frameworks, together with close clinician-laboratory collaboration. Greater awareness of analytical interference is critical as cardiology becomes increasingly biomarker-driven. Integrating clinical judgment with structured laboratory verification can substantially reduce diagnostic error, improve patient safety, and prevent avoidable healthcare utilization in contemporary cardiovascular practice.

1 April 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
KSKadriye Memic Sancar
Kadriye Memic Sancar
OÇOğuzhan Çelik
Oğuzhan Çelik
CCCem Cil
Cem Cil
OKOsman Karaarslan
Osman Karaarslan
TDTolga Doğan
Tolga Doğan
MBMurat Biteker
Murat Biteker
Aspirin,hypertension,primary prevention,secondary prevention,Turkey

14 May 2026 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Open access
OKOsman Karaarslan
Osman Karaarslan
MYMehmet Mustafa Yılmaz
Mehmet Mustafa Yılmaz
MKMacit Kalçık
Macit Kalçık

11 May 2026 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Open access
PDF file
MYMehmet Mustafa Yılmaz
Mehmet Mustafa Yılmaz
OKOsman Karaarslan
Osman Karaarslan
MKMacit Kalçık
Macit Kalçık
Click on the article title to read more.